Identification of a novel peptide ligand targeting visceral adipose tissue via transdermal route by in vivo phage display

Journal of Drug Targeting

Volumn 19, Issue 9, 2011, Pages 805-813

  Lee, Nam Kyung ^a   Kim, Hong Shin ^a   Kim, Kyung Hyun ^a   Kim, Eun Bae ^a   Cho, Chong Su ^a   Kang, Sang Kee ^a   Choi, Yun Jaie ^a  

^a Seoul National University   (South Korea)

Author keywords

Hair follicle; Phage display; Targeting delivery; Transdermal drug delivery; Visceral fat

Indexed keywords

LIGAND; PEPTIDE DERIVATIVE; TDA1 PEPTIDE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BIOPANNING; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG TARGETING; FLUORESCENCE MICROSCOPY; HAIR FOLLICLE; IN VITRO STUDY; MALE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; RAT; VALIDATION STUDY;

3T3-L1 CELLS; ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; HAIR FOLLICLE; INTRA-ABDOMINAL FAT; LIGANDS; MALE; MICE; MICROSCOPY, FLUORESCENCE; PEPTIDE LIBRARY; PEPTIDES; RATS; RATS, WISTAR;

EID: 80054709318     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2011.572974     Document Type: Article

References (21)

1. Andreotti F, Rio T, Lavorgna A. (2009). Body fat and cardiovascular risk: understanding the obesity paradox. Eur Heart J, 30, 752-754
2. Arap W, Haedicke W, Bernasconi M, Kain R, Rajotte D, Krajewski S, Ellerby HM, Bredesen DE, Pasqualini R, Ruoslahti E. (2002). Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci USA, 99, 1527-1531 (Pubitemid 34136526)
3. Arap W, Pasqualini R, Ruoslahti E. (1998). Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 279, 377-380 (Pubitemid 28063372)
4. Benson HA, Namjoshi S. (2008). Proteins and peptides: strategies for delivery to and across the skin. J Pharm Sci, 97, 3591-3610
5. Chen Y, Shen Y, Guo X, Zhang C, Yang W, Ma M, Liu S, Zhang M, Wen LP. (2006). Transdermal protein delivery by a coadministered peptide identified via phage display. Nat Biotechnol, 24, 455-460
6. Clapham JC, Arch JR, Tadayyon M. (2001). Anti-obesity drugs: a critical review of current therapies and future opportunities. Pharmacol Ther, 89, 81-121 (Pubitemid 32367885)
7. Després JP, Lemieux I. (2006). Abdominal obesity and metabolic syndrome. Nature, 444, 881-887 (Pubitemid 46024995)
8. Dias-Neto E, Nunes DN, Giordano RJ, Sun J, Botz GH, Yang K, Setubal JC, Pasqualini R, Arap W. (2009). Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis. PLoS ONE, 4, e8338
9. Goldstein AL, Johnson PR. (1982). Primary culture of adipoblasts from obese and lean Zucker rat adipose tissue. Metab Clin Exp, 31, 601-607 (Pubitemid 12112252)
10. Hsiung PL, Hsiung PL, Hardy J, Friedland S, Soetikno R, Du CB, Wu AP, Sahbaie P, Crawford JM, Lowe AW, Contag CH, Wang TD. (2008). Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med, 14, 454-458 (Pubitemid 351499384)
11. Kang SK, Woo JH, Kim MK, Woo SS, Choi JH, Lee HG, Lee NK, Choi YJ. (2008). Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells. J Biotechnol, 135, 210-216
12. Kim YC, Ludovice PJ, Prausnitz MR. (2007). Transdermal delivery enhanced by magainin pore-forming peptide. J Control Release, 122, 375-383 (Pubitemid 47404674)
13. Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A. (2009). Follicular transport route-research progress and future perspectives. Eur J Pharm Biopharm, 71, 173-180
14. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. (2004). Reversal of obesity by targeted ablation of adipose tissue. Nat Med, 10, 625-632 (Pubitemid 38796854)
15. Kopelman PG. (2000). Obesity as a medical problem. Nature, 404, 635-643 (Pubitemid 30205068)
16. Lee L, Buckley C, Blades MC, Panayi G, George AJ, Pitzalis C. (2002). Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum, 46, 2109-2120
17. Prausnitz MR, Langer R. (2008). Transdermal drug delivery. Nat Biotechnol, 26, 1261-1268
18. Prausnitz MR, Mitragotri S, Langer R. (2001). Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov, 3, 115-124
19. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. (1997). The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res, 25, 4876-4882
20. Todo H, Kimura E, Yasuno H, Tokudome Y, Hashimoto F, Ikarashi Y, Sugibayashi K. (2010). Permeation pathway of macromolecules and nanospheres through skin. Biol Pharm Bull, 33, 1394-1399
21. Wan XM, Chen YP, Xu WR, Yang WJ, Wen LP. (2009). Identification of nose-to-brain homing peptide through phage display. Peptides, 30, 343-350